Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$0.23 - $0.35 $6,241 - $9,497
-27,137 Reduced 50.97%
26,106 $6,000
Q4 2023

Feb 14, 2024

BUY
$0.21 - $0.36 $11,181 - $19,167
53,243 New
53,243 $17,000
Q2 2023

Aug 14, 2023

BUY
$0.46 - $0.81 $21,357 - $37,608
46,430 New
46,430 $23,000
Q4 2022

Feb 14, 2023

BUY
$0.29 - $0.47 $12,826 - $20,788
44,231 New
44,231 $15,000

Others Institutions Holding ASXC

About ASENSUS SURGICAL, INC.


  • Ticker ASXC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 236,719,008
  • Market Cap $82.9M
  • Description
  • Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical int...
More about ASXC
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.